Trademark: 87603285
Word
OZOFTA
Status
Dead
Status Code
606
Status Date
Monday, February 22, 2021
Serial Number
87603285
Mark Type
4000
Filing Date
Monday, September 11, 2017
Published for Opposition
Tuesday, November 21, 2017
Abandoned Date
Monday, February 22, 2021

Trademark Owner History
Novartis AG - Owner At Publication

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Trademark Events
Feb 22, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 22, 2021
Abandonment - No Use Statement Filed
Aug 6, 2020
Notice Of Approval Of Extension Request E-Mailed
Aug 5, 2020
Extension 5 Granted
Jul 8, 2020
Extension 5 Filed
Aug 4, 2020
Case Assigned To Intent To Use Paralegal
Jul 8, 2020
Teas Extension Received
Jan 14, 2020
Notice Of Approval Of Extension Request E-Mailed
Jan 10, 2020
Extension 4 Granted
Jan 10, 2020
Extension 4 Filed
Jan 10, 2020
Teas Extension Received
Jul 16, 2019
Notice Of Approval Of Extension Request E-Mailed
Jul 12, 2019
Extension 3 Granted
Jul 12, 2019
Extension 3 Filed
Jul 12, 2019
Teas Extension Received
Jan 16, 2019
Notice Of Approval Of Extension Request E-Mailed
Jan 14, 2019
Extension 2 Granted
Jan 14, 2019
Extension 2 Filed
Jan 14, 2019
Teas Extension Received
Jul 17, 2018
Notice Of Approval Of Extension Request E-Mailed
Jul 13, 2018
Extension 1 Granted
Jul 13, 2018
Extension 1 Filed
Jul 13, 2018
Teas Extension Received
Jan 16, 2018
Noa E-Mailed - Sou Required From Applicant
Nov 21, 2017
Official Gazette Publication Confirmation E-Mailed
Nov 21, 2017
Published For Opposition
Nov 1, 2017
Notification Of Notice Of Publication E-Mailed
Oct 10, 2017
Approved For Pub - Principal Register
Oct 6, 2017
Assigned To Examiner
Sep 15, 2017
New Application Office Supplied Data Entered In Tram
Sep 14, 2017
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24